Racial Disparity Exists in Larynx Preserving Surgery

This article originally appeared here.
Share this content:
Racial Disparity Exists in Larynx Preserving Surgery
Racial Disparity Exists in Larynx Preserving Surgery

(HealthDay News) – Racial disparities exist in the use of larynx preservation for locally advanced laryngeal cancer, most notably among black patients, according to research published in the July issue of the Archives of Otolaryngology – Head & Neck Surgery.

Wei-Hsien Hou, MD, PhD, from the University of California in Davis, and colleagues examined potential racial disparities in the use of larynx preservation in 5,385 patients with stage III and IV laryngeal cancer without T4 disease or distant metastasis.

The researchers found that, of the cases, 72.7% were white, 16.8% black, 7.4% Hispanic, and 3.1% Asian. Blacks were found to be significantly less likely to undergo larynx preservation, on univariate analysis (odds ratio [OR], 0.72). On multivariate analysis, the racial disparity persisted for blacks (OR, 0.78) and was also seen for the subgroup of more recently treated patients (2001 to 2008; OR, 0.74).

"Pronounced racial disparities exist in the use of larynx preservation therapy for locally advanced laryngeal cancer," the authors write. "While acknowledging the potential biases of socioeconomic factors, further research to better elucidate the underlying reasons for these findings may be warranted."

Abstract
Full Text

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs